Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-64.35%
operating margin TTM
-67.36%
revenue TTM
869.35 Million
revenue per share TTM
5.47$
valuation ratios | |
|---|---|
| pe ratio | -8.92 |
| peg ratio | 0.34 |
| price to book ratio | 6.88 |
| price to sales ratio | 6.11 |
| enterprise value multiple | -8.74 |
| price fair value | 6.88 |
profitability ratios | |
|---|---|
| gross profit margin | 96.82% |
| operating profit margin | -67.36% |
| pretax profit margin | -65.23% |
| net profit margin | -64.35% |
| return on assets | -15.11% |
| return on equity | -100.25% |
| return on capital employed | -17.63% |
liquidity ratio | |
|---|---|
| current ratio | 8.47 |
| quick ratio | 8.43 |
| cash ratio | 0.78 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 203.46 |
| operating cycle | 251.17 |
| days of payables outstanding | 698.65 |
| cash conversion cycle | -447.48 |
| receivables turnover | 7.65 |
| payables turnover | 0.52 |
| inventory turnover | 1.79 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.47 |
| debt equity ratio | 2.41 |
| long term debt to capitalization | 0.68 |
| total debt to capitalization | 0.71 |
| interest coverage | -5.53 |
| cash flow to debt ratio | -0.35 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.69 |
| cash per share | 15.37 |
| operating cash flow per share | -3.35 |
| free cash flow operating cash flow ratio | 1.10 |
| cash flow coverage ratios | -0.35 |
| short term coverage ratios | -53.99 |
| capital expenditure coverage ratio | -10.47 |
Frequently Asked Questions
When was the last time Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) reported earnings?
Ionis Pharmaceuticals, Inc. (IONS) published its most recent earnings results on 06-11-2024.
What is Ionis Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)'s trailing twelve months ROE is -100.25%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ionis Pharmaceuticals, Inc. (IONS) currently has a ROA of -15.11%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IONS's net profit margin stand at?
IONS reported a profit margin of -64.35% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IONS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.47 in the most recent quarter. The quick ratio stood at 8.43, with a Debt/Eq ratio of 2.41.